Cardio Diagnostics Holdings, Inc.CDIO
Price (close)
$1.95
Market cap
$5.8M
P/E
—
Revenue (TTM)
$14,450
Net income
-$6.5M
Dividend yield
—
1-year total return
-52.0%
Net margin
-44771.8%
Revenue growth
-25.9%
Debt / equity
—
What Cardio Diagnostics Holdings, Inc. does.
a series of products for major types of cardiovascular disease and associated co-morbidities, including coronary heart disease (“CHD”),
stroke, heart failure and diabetes, by leveraging our Artificial Intelligence (“AI”)-driven Multi-Omics Engine™ (formerly
company, we aspire to give every American adult insight into their unique risk for various cardiovascular diseases. Cardio aims to become
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | $901 | $950 | $17,065 | $34,890 | $14,825 |
| Net income | — | -$620,448 | -$4.7M | -$8.4M | -$8.4M | -$6.5M |
| Free cash flow | — | — | — | -$6.2M | -$5.2M | -$5.9M |
More on CDIO.
- Cardio Diagnostics Holdings, Inc. summary
- Cardio Diagnostics Holdings, Inc. financial statements
- Cardio Diagnostics Holdings, Inc. key metrics
- Cardio Diagnostics Holdings, Inc. health scores and style box
- Cardio Diagnostics Holdings, Inc. earnings
- Cardio Diagnostics Holdings, Inc. dividends
- Cardio Diagnostics Holdings, Inc. valuation
- Cardio Diagnostics Holdings, Inc. ownership and insiders
- Cardio Diagnostics Holdings, Inc. peers
Figures from Cardio Diagnostics Holdings, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.